SEC Filing Summary: AspenBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio, Inc. on July 12, 2005. The registrant is incorporated in Colorado with principal executive offices in Castle Rock, CO. The report discloses the completion of a private placement financing event.
Key Financial Metrics
The filing reports the successful completion and termination of a private placement raising $3,557,892. The document does not provide specific data regarding revenue, profit, operating cash flow, margins, existing debt levels, or liquidity ratios beyond the proceeds from this specific transaction.
Material Changes
The primary material change is the increase in capital resulting from the private placement. No comparative financial data or changes versus prior periods are included in this specific current report.
Outlook, Risks, and Management Commentary
Management commentary is limited to the announcement of the financing completion. The filing references a press release (Exhibit 99.1) for further details but does not contain explicit forward-looking guidance, risk factors, or contingencies within the text of the 8-K itself.
Investor Verification Checklist
- Verify the terms of the private placement (e.g., security type, valuation, use of proceeds) in the referenced press release (Exhibit 99.1).
- Confirm the current cash position and liquidity status of AspenBio, Inc. following the $3.56 million infusion.
- Review the company's latest 10-K or 10-Q for baseline revenue and debt metrics not present in this 8-K.
- Note the discrepancy between the requested company name (Riot Platforms, Inc.) and the actual registrant in the filing text (AspenBio, Inc.).